- ¥136bn
- ¥128bn
- ¥19bn
Brief: PeptiDream announces discovery collaboration agreement with Bayer AG
Table: Peptidream - Q1 parent results
Brief: PeptiDream announces change of chairman and president
Refile: TABLE-Peptidream -2016/17 parent results
Table: Peptidream -2016/17 parent results
Brief: PeptiDream to set up Osaka-based special peptide drugs JV
Brief: Sosei Group subsidiary Heptares enters strategic collaboration with PeptiDream
Table: Peptidream -2016/17 parent forecast
Brief: PeptiDream announces licensing of peptide discovery platform system (PDPS) technology to Shionogi
Table: Peptidream - 9-MTH parent results
Brief: PeptiDream enters into collaboration with Janssen Pharmaceuticals
Table: Peptidream -6-MTH parent results
Table: Peptidream -Q1 parent results
Table: Peptidream -2015/16 parent results
Brief: Peptidream announces license of PDPS technology to Genentech Inc
Brief: PeptiDream achieves milestone for initiation of clinical development for bristol-myers squibb's first collaboration product candidate
Table: Peptidream -2015/16 parent forecast
Table: Peptidream -9-MTH parent results
Brief: PeptiDream says entered into technology license agreement with Eli Lilly